SCHEMBL15057598

SCHEMBL15057598

CCCCNC(=O)C1COC(=O)O1

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.66
POLB P06746 1/20 0.44
BCHE P06276 1/20 0.44
ALOX5 P09917 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
NAAA Q02083 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16493476 0.94 HPGD (0.59) HPGDPOLBNAAA
SCHEMBL16335507 0.94 HPGD (0.59) HPGDPOLBNAAA
SCHEMBL15074767 0.94 HPGD (0.59) HPGDPOLBNAAA
SCHEMBL15074765 0.88 HPGD (0.51) HPGDPOLBLMNAKMT2AMEN1
SCHEMBL19688989 0.82 HPGD (0.47) HPGDPOLBKMT2AMEN1GAA
SCHEMBL19688991 0.80 HPGD (0.45) HPGDPOLBLMNAKMT2AMEN1
SCHEMBL15716575 0.79 BCHE (0.56) HPGDPOLBBCHELMNASMN1; SMN2
SCHEMBL22198070 0.76 HPGD (0.52) HPGDBCHELMNASMN1; SMN2KMT2A
SCHEMBL19320497 0.76 POLB (0.42) HPGDPOLBLMNASMN1; SMN2KMT2A
SCHEMBL10536013 0.74 NAAA (0.54) HPGDPOLBBCHENAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210324141-A1 METHOD FOR PRODUCING NON-ISOCYANATE POLYURETHANES HENKEL AG & CO. KGAA (DE) 2021-10-21 US disclosed
EP-3677616-A1 METHOD FOR PRODUCING NON-ISOCYANATE POLYURETHANES Henkel AG & Co. KGaA (DE) 2020-07-08 EP disclosed
EP-3013811-B1 2-OXO-1,3-DIOXOLANE-4-ACYL HALIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-07-12 EP disclosed
EP-3013811-B1 2-OXO-1,3-DIOXOLANE-4-ACYL HALIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-07-12 EP disclosed
US-9643948-B2 2-oxo-1,3-dioxolane-4-acyl halides, their preparation and use CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-05-09 US disclosed
US-9643948-B2 2-oxo-1,3-dioxolane-4-acyl halides, their preparation and use CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-05-09 US disclosed
US-9643948-B2 2-oxo-1,3-dioxolane-4-acyl halides, their preparation and use CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-05-09 US disclosed
EP-2794585-B1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE CONSTR RES & TECH GMBH (DE) 2016-06-15 EP disclosed
EP-2794585-B1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE CONSTR RES & TECH GMBH (DE) 2016-06-15 EP disclosed
US-20160145232-A1 2-OXO-1,3-DIOXOLANE-4-ACYL HALIDES, THEIR PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2016-05-26 US disclosed
US-20150051365-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2015-02-19 US disclosed
US-20150051365-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2015-02-19 US disclosed
US-20150051365-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2015-02-19 US disclosed
EP-2818465-A1 2-Oxo-1,3-dioxolane-4-acyl halides, their preparation and use Construction Research & Technology GmbH (DE) 2014-12-31 EP disclosed
WO-2014206636-A1 2-OXO-1,3-DIOXOLANE-4-ACYL HALIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2014-12-31 WO disclosed
EP-2818465-A1 2-Oxo-1,3-dioxolane-4-acyl halides, their preparation and use Construction Research & Technology GmbH (DE) 2014-12-31 EP disclosed
WO-2014206636-A1 2-OXO-1,3-DIOXOLANE-4-ACYL HALIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2014-12-31 WO disclosed
EP-2794585-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE Construction Research & Technology GmbH (DE) 2014-10-29 EP disclosed
WO-2013092011-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2013-06-27 WO disclosed
WO-2013092011-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210324141-A1 METHOD FOR PRODUCING NON-ISOCYANATE POLYURETHANES UROD, IDH3A, SQLE HPGD 66/4885POLB 1386/4885BCHE 103/4885
US-20160145232-A1 2-OXO-1,3-DIOXOLANE-4-ACYL HALIDES, THEIR PREPARATION AND USE AOX1, AOC2, AOC1 HPGD 1516/4885POLB 1794/4885BCHE 1148/4885
US-20150051365-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE HAO2, OXGR1, AOX1 HPGD 170/4885POLB 610/4885BCHE 3638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.